X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (76) 76
science & technology (72) 72
female (67) 67
life sciences & biomedicine (65) 65
obstetrics & gynecology (38) 38
middle aged (35) 35
oncology (34) 34
cancer (27) 27
obstetrics and gynecology (27) 27
adult (23) 23
hematology, oncology and palliative medicine (21) 21
aged (20) 20
ovarian cancer (20) 20
analysis (16) 16
pregnancy (16) 16
neoplasm staging (14) 14
proportional hazards models (14) 14
retrospective studies (14) 14
survival (14) 14
chemotherapy (13) 13
kaplan-meier estimate (13) 13
research (12) 12
abridged index medicus (11) 11
cell line, tumor (11) 11
chemotherapy, adjuvant (11) 11
hysterectomy (11) 11
metastasis (11) 11
prognosis (11) 11
endometrial cancer (10) 10
ovarian neoplasms - drug therapy (10) 10
databases, factual (9) 9
ovarian neoplasms - metabolism (9) 9
antineoplastic agents - therapeutic use (8) 8
cohort studies (8) 8
multivariate analysis (8) 8
ovarian neoplasms - pathology (8) 8
chorionic gonadotropin - blood (7) 7
chorionic gonadotropin - urine (7) 7
oncology, experimental (7) 7
ovarian neoplasms - genetics (7) 7
prenatal diagnosis (7) 7
research article (7) 7
survival rate (7) 7
uterine neoplasms - pathology (7) 7
aged, 80 and over (6) 6
care and treatment (6) 6
endometrial neoplasms - pathology (6) 6
false positive reactions (6) 6
gestational age (6) 6
health aspects (6) 6
human necessities (6) 6
hygiene (6) 6
medical or veterinary science (6) 6
multidisciplinary sciences (6) 6
ovarian neoplasms - mortality (6) 6
ovarian neoplasms - therapy (6) 6
proteins (6) 6
science & technology - other topics (6) 6
specific therapeutic activity of chemical compounds ormedicinal preparations (6) 6
survival analysis (6) 6
tumors (6) 6
womens health (6) 6
adenocarcinoma - pathology (5) 5
adjuvant treatment (5) 5
biomarkers (5) 5
case report (5) 5
chorionic gonadotropin (5) 5
down syndrome (5) 5
down syndrome - diagnosis (5) 5
drug resistance, neoplasm (5) 5
endometrial neoplasms - surgery (5) 5
gene expression (5) 5
gynecology (5) 5
hospitals (5) 5
immunohistochemistry (5) 5
lymph nodes - pathology (5) 5
medicine (5) 5
paclitaxel - pharmacology (5) 5
patients (5) 5
prenatal diagnosis - methods (5) 5
research paper (5) 5
sensitivity and specificity (5) 5
treatment outcome (5) 5
uterine neoplasms - mortality (5) 5
uterine neoplasms - therapy (5) 5
women (5) 5
young adult (5) 5
age (4) 4
antineoplastic agents - pharmacology (4) 4
biochemistry (4) 4
cell biology (4) 4
cervical cancer (4) 4
creatinine - urine (4) 4
diagnosis, differential (4) 4
disease-free survival (4) 4
drug resistance (4) 4
endometrial neoplasms - mortality (4) 4
epothilones - pharmacology (4) 4
genetics & heredity (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 11/2018, Volume 379, Issue 20, pp. 1905 - 1914
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2017, Volume 145, Issue 1, pp. 9 - 14
Abstract Objectives To determine the cost-effectiveness of dose-dense versus standard intravenous adjuvant chemotherapy for ovarian cancer using results from... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Oncology | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Drug Costs | Markov Chains | Peripheral Nervous System Diseases - chemically induced | Hematologic Agents - economics | Blood Transfusion - economics | Humans | Hospitalization - statistics & numerical data | Antineoplastic Agents - administration & dosage | Blood Transfusion - statistics & numerical data | Neoplasms, Glandular and Epithelial - economics | Female | Filgrastim - therapeutic use | Chemotherapy, Adjuvant | Neutropenia - chemically induced | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Paclitaxel - economics | Decision Support Techniques | Hematologic Agents - therapeutic use | Proportional Hazards Models | Anemia - chemically induced | Anemia - therapy | Peripheral Nervous System Diseases - economics | Neutropenia - economics | Antineoplastic Agents - economics | Neutropenia - drug therapy | Randomized Controlled Trials as Topic | Disease-Free Survival | Filgrastim - economics | Administration, Intravenous | Ovarian Neoplasms - economics | Cost-Benefit Analysis | Neoplasms, Glandular and Epithelial - drug therapy | Anemia - economics | Carcinoma, Ovarian Epithelial | Hospitalization - economics | Cost benefit analysis | Analysis | Ovarian cancer | Adjuvant treatment | Cancer | Index Medicus
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2016, Volume 143, Issue 3, pp. 636 - 641
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2014, Volume 136, Issue 2, pp. 394 - 394
Journal Article
American journal of obstetrics and gynecology, ISSN 0002-9378, 01/2018, Volume 218, Issue 1, pp. 103.e1 - 103.e5
Journal Article
Current pharmaceutical design, ISSN 1381-6128, 06/2012, Volume 18, Issue 19, pp. 2793 - 2803
Journal Article
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2016, Volume 143, Issue 3, pp. 472 - 478
Abstract Objective To determine overall survival (OS) and factors associated with OS after pelvic exenteration for uterine cancer. Methods Women with uterine... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Exenteration | Prognosis | Survival | Uterine neoplasms | Oncology | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Multivariate Analysis | Neoplasms, Cystic, Mucinous, and Serous - surgery | Adenocarcinoma - pathology | Lymph Nodes - pathology | Carcinosarcoma - surgery | Uterine Neoplasms - pathology | Adenocarcinoma, Clear Cell - mortality | Humans | Middle Aged | Insurance, Health - statistics & numerical data | Protective Factors | Carcinoma, Endometrioid - surgery | Carcinosarcoma - mortality | Sarcoma - mortality | Uterine Neoplasms - mortality | Female | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Databases, Factual | Adenocarcinoma, Clear Cell - surgery | Carcinosarcoma - pathology | Neoplasms, Cystic, Mucinous, and Serous - pathology | Risk Factors | Kaplan-Meier Estimate | Margins of Excision | Proportional Hazards Models | Survival Rate | Tumor Burden | Sarcoma - pathology | Uterine Neoplasms - surgery | Carcinoma, Endometrioid - mortality | Sarcoma - surgery | Pelvic Exenteration | Adenocarcinoma, Clear Cell - pathology | Aged | Neoplasm Staging | Carcinoma, Endometrioid - pathology | Neoplasms, Cystic, Mucinous, and Serous - mortality | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Databases | Research | Oncology, Experimental | Cancer | Index Medicus
Journal Article